XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2022
Stockholders' Equity  
Stockholders' Equity

11.Stockholders’ Equity

Common Stock

In connection with the closing of the Business Combination, the Company authorized the issuance of 700,000,000 shares of Class A common stock, par value $0.0001 per share, 20,000,000 shares of Class B common stock, par value $0.0001 per share, and 10,000,000 shares of Class C common stock, par value $0.0001 per share. Each share of Class A common stock is entitled to one vote and each share of Class B common stock is entitled to fifty votes. Class C common stock is non-voting.

Preferred Stock

In connection with the closing of the Business Combination, the Company authorized the issuance of 50,000,000 shares of preferred stock, par value $0.0001 per share. The board of directors is authorized, without further stockholder approval, to issue such preferred stock in one or more series, to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. There were no issued and outstanding shares of preferred stock as of March 31, 2022 or December 31, 2021.

Stock-Based Compensation

Stock Options

A summary of the stock option activity under the Company’s equity incentive plans is presented below:

    

    

Weighted

    

Weighted

    

Average

Average

Aggregate 

Number of

Exercise

Remaining

Intrinsic

    

Shares

    

Price

    

Term

    

 Value

Balance as of December 31, 2021

 

4,560

$

6.29

 

3.07

$

2,670

Granted

 

593

 

4.33

Exercised

 

(308)

 

1.02

Forfeited

 

(83)

 

6.48

Expired

 

(407)

 

7.38

Balance as of March 31, 2022

 

4,355

6.29

 

4.03

1,766

Expected to vest at March 31, 2022

 

4,355

6.29

 

4.03

1,766

Exercisable at March 31, 2022

 

3,274

6.18

 

2.38

1,261

As of March 31, 2022, the total share-based compensation costs not yet recognized related to unvested stock options was $3.0 million, which is expected to be recognized over the weighted-average remaining requisite service period of 1.5 years.

Restricted Stock Units

A summary of Restricted Stock Unit (“RSU”) activity is presented below:

Weighted Average Grant-

    

Shares

    

Date Fair Value

Outstanding as of December 31, 2021

 

5,235

$

8.88

Granted

 

4,438

 

4.33

Vested

 

(167)

 

5.73

Forfeited

 

(32)

 

6.32

Outstanding as of March 31, 2022

 

9,474

$

6.82

As of March 31, 2022, there was approximately $23.3 million of unrecognized compensation costs related to RSUs. Included in the above are 2.5 million RSUs that vest based on service and upon the occurrence of a sale transaction (“Acquisition”) or the completion of an initial public offering (“Liquidity 1 RSUs”). The Two-Step Merger did not result in the satisfaction of this liquidity condition as it does not meet the definition of an Acquisition per the award agreements. Unrecognized compensation costs related to these RSUs totaled $21.2 million at March 31, 2022.

On May 12, 2022, the Board of Directors waived the liquidity condition associated with the Liquidity 1 RSUs, permitting them to vest (based on service). Refer to Note 20 of our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information with respect to the Liquidity 1 RSUs and the waiver.

Stock-Based Compensation Expense

The following table summarizes stock-based compensation cost included in the condensed consolidated statements of operations:

    

Three Months Ended March 31,

2022

    

2021

Cost of revenue, excluding depreciation and amortization

$

460

$

42

Sales and marketing

 

722

 

29

General and administrative

 

2,598

 

54

Research and development

 

160

 

13

Total

$

3,940

$

138